Home/ Interactions/ Vitamin K × Warfarin
AI-generated · Qwen 3.6 · grounded in 2 sources · last updated 2026-04-17 · methodology

Can I take Vitamin K with Warfarin?

Answer

No, you should not take vitamin K supplements while using warfarin without strict medical supervision. Vitamin K directly antagonizes the effects of warfarin, which can lead to a dangerous increase in the risk of blood clots (thrombosis).

Evidence Assessment

The evidence regarding the interaction between vitamin K and warfarin is well-established and categorized as Strong Evidence (Tier A). The mechanism of action is clinically definitive, and the interaction is recognized as critical in pharmacological labeling.

Clinical Evidence

Warfarin is a vitamin K antagonist that works by inhibiting the enzyme vitamin K epoxide reductase, which is essential for the synthesis of clotting factors II, VII, IX, and X. When supplemental vitamin K is introduced, it bypasses this inhibition, effectively neutralizing the anticoagulant effect of the drug.

Clinical reviews have explored the use of low-dose vitamin K to help stabilize the International Normalized Ratio (INR) in patients who struggle with overcoagulation (excessive bleeding) [PMID:24832594]. However, for the general population, uncontrolled intake of vitamin K leads to "undercoagulation," where the blood clots too easily, defeating the purpose of the therapy.

Practical Guidance

  • Dietary Consistency: Patients on warfarin are advised to maintain a consistent daily intake of vitamin K-rich foods (such as leafy greens) rather than avoiding them entirely. Sudden increases or decreases in dietary vitamin K can destabilize the INR.
  • Supplementation: Avoid vitamin K supplements exceeding 150mcg/day unless specifically prescribed by a healthcare provider for INR stabilization.
  • Monitoring: Any change in vitamin K intake (dietary or supplemental) requires close monitoring of the INR to adjust the warfarin dose accordingly.

Safety & Interactions

  • Contraindication: CRITICAL. Supplemental vitamin K directly antagonizes warfarin.
  • Mechanism: Vitamin K provides the necessary cofactor for the gamma-carboxylation of clotting factors, which warfarin is designed to prevent.
  • Clinical Management:
    • Avoid high-dose vitamin K supplements.
    • Monitor INR closely during any dietary changes.
    • Report any new supplements or medications to the prescribing physician immediately.
  • High-Risk Populations: Patients with a history of deep vein thrombosis (DVT), pulmonary embolism, or those with mechanical heart valves are at extreme risk if warfarin efficacy is reduced by vitamin K [PMID:29199766]. Consult a physician before making any changes to your supplement regimen.
Do not combine without physician supervision. If you are already taking both Vitamin K and Warfarin, contact your healthcare provider today. Do not stop any medication without professional guidance.

Vitamin K × Warfarin

CRITICAL Well-Established Evidence

Mechanism

Vitamin K is required for synthesis of clotting factors II, VII, IX, X. Warfarin inhibits vitamin K epoxide reductase. Supplemental vitamin K directly antagonizes warfarin's anticoagulant effect.

Effect

Reduced anticoagulant effect; increased thrombosis risk

Management

Avoid vitamin K supplements >150mcg/day. Maintain consistent dietary vitamin K intake. Monitor INR closely with any changes.

Plain Language Summary

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This combination is dangerous because Vitamin K supplements can directly counteract the effects of Warfarin. This makes the medication less effective at thinning your blood, which increases the risk of developing blood clots.

Source

FDA warfarin labeling; Holbrook AM et al. Ann Intern Med 2005

Research

Supporting Research

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Antiplatelet agents and anticoagulants for hypertension
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
← Vitamin K All Interactions →

Medical Disclaimer: This interaction record is for informational and educational purposes only and does not constitute medical advice. Always consult your healthcare provider or pharmacist before combining any supplement with prescription medications.